STEERING COMMITTEE OF MEDICADEMY PHARMACOVIGILANCE

The Steering Commitee of Medicademy Pharmacovigilance comprises members from the industry,
the authorities and universities. The Steering Commitee is responsible for the professional framework of the programme and the continuous development of the individual modules, including scope, contents, level
and uniformity.

As of March 1, 2011, the Steering Commitee is composed by the following members:

DORIS STENVER,
MD, MPA, Chief Medical Officer, EU Pharmacovigilance Working Party Delegate, ¬Danish Medicines Agency

EA DIGE,
EU-Qualified Person for Pharmacovigilance, Director, ALK Abelló A/S

ELLEN RAVN ENGLEV,
MSc Pharm, Director, Case Management I, Safety Operations, Global Safety, Novo Nordisk A/S

HENRIK KØHLER SIMONSEN,
PhD, Head of Department, Lif Education, Exhibition & Medicademy

JESPER HALLAS,
Professor, dr. med, University of Southern Denmark

KARSTEN LOLLIKE,
Corporate Vice President, QPPV, Novo Nordisk A/S (Chairman)

KLAUS GRØNBÆK JAKOBSEN,
Senior Director, Head of International Drug Safety, Nycomed Aps

LENNART WALDENLIND,
MD, PhD, Clinical Assessor, Signal Detection, Medical Products Agency, Sweden

LESLIE KRAUSE,
MD, Associate Vice President, Qualified Person for Pharmacovigilance, Ferring Pharmaceuticals A/S

LONE MUNK HANSEN,
Drug Safety and Regulatory Manager, Scandinavia, Eli Lilly

PER HARTVIG HONORÉ,
PharmD, PhD, Professor in Pharmacokinetics, Copenhagen University

TINA ELBERLING,
Head of Department, Global Pharmacovigilance, LEO Pharma A/S

MINNA KJÆR JØRGENSEN,
M.Sc. Technological & Socio Economic Planning, Program Director Medicademy Pharmacovigilance